Additionally, the scientists learned the ACKR3 receptor at high concentrations in vital brain areas which are also significant opioid activity centers.These results counsel that conolidine is able to limit the ACKR3 receptor’s destructive regulatory properties and liberate opioid peptides, permitting them to bind to your classical opioid receptor